, Singapore

Daily Markets Briefing: STI up 0.48%

Expect muted gains today.

The Straits Times Index (STI) ended 17.16 points or 0.48% higher to 3609.24, taking the year-to-date performance to +6.06%.

The top active stocks were DBS, which gained 1.23%, Sembcorp Marine, which declined 1.95%, Genting Sing, which gained 4.51%, Singtel, which gained 0.83% and Midas, with a 5.00% advance.

The FTSE ST Mid Cap Index declined 0.02%, while the FTSE ST Small Cap Index rose 0.16%. 

OCBC Investment Research noted US stocks retreated from record territory Wednesday as technology names came under pressure, but the Dow managed to buck the trend to close higher on the back of a few blue-chip financial shares.

Five out of 11 S&P 500 industries finished lower, with Information Technology, which fell 0.91%, and Utilities, which fell 0.59%, leading the declines whilst Financials, which rose 0.68%, and Telecommunication Services, which rose 0.66%, led the gains.

"The mixed performances on Wall Street overnight are unlikely to provide much inspiration to the local bourse today," OCBC said.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare